Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients. The company identifies rare bioactive compounds and, through rigorous research, develops those with the greatest potential for human health and wellbeing. Conversations about rare cannabinoid activity are just beginning and over the past year. Demetrix has advanced its knowledge far beyond THC and CBD. Most of these rarer cannabinoids have not yet been studied in depth, and Demetrix is proud to be bringing scientific rigor to the space.Our research so far has shown that cannabinoids hold a great deal of promise for health and beauty. Discover why these bioactives are so important for personal care, and learn more about our research and journey to initiating commercial manufacturing earlier this year.
Date: Tuesday 26th July
Time: 11:00am EST/ 16:00 BST
Participants will learn: